Brook.ai Secures $28 Million to Transform Remote Healthcare with AI
In a significant development for healthcare technology, Seattle-based Brook.ai has successfully raised $28 million in Series B funding, led by UMass Memorial Health and Morningside. Founded in 2015, the company has evolved from its initial focus on diabetes management to become a comprehensive platform addressing multiple chronic conditions. CEO Oren Nissim, who previously sold his mobile services company Telmap to Intel in 2012, co-founded Brook with Chief Product Officer Kit Macgillivray, bringing their shared experience to tackle one of healthcare’s most pressing challenges – effective remote care for chronic conditions.
Brook.ai’s innovative approach combines sophisticated data analytics, timely automated nudges, and personalized support from clinicians and health coaches to create a holistic remote care experience. What sets Brook apart in the crowded healthtech space is their turnkey system, which can be deployed within just 30 days – a remarkable timeline in an industry often plagued by lengthy implementation periods. This rapid deployment capability, combined with their comprehensive care model, has helped patients better manage conditions like congestive heart failure and hypertension from the comfort of their homes. The platform’s effectiveness is reflected in impressive metrics: reduced hospital readmissions, improved hypertension control, and most tellingly, an 82% patient retention rate – a strong indicator of user satisfaction in healthcare technology.
The timing of Brook’s expansion couldn’t be more opportune, as the healthcare landscape undergoes significant transformation. Policy shifts and evolving reimbursement models increasingly favor remote and home-based care solutions, creating a fertile environment for companies that can effectively bridge the gap between clinical settings and patients’ daily lives. Brook’s remarkable 204% patient growth over the past year speaks to this market opportunity and the company’s ability to capitalize on it. Starting with diabetes management and gradually expanding to include hypertension, metabolic health, and general chronic disease care, Brook has demonstrated the versatility and scalability of its platform – essential qualities for success in the rapidly evolving healthcare technology sector.
Despite the promising trajectory, Brook and similar companies face substantial challenges in the remote healthcare market. Complex data integration remains a persistent obstacle, requiring seamless connections between various devices, electronic health records, and patient-reported information. Additionally, healthcare organizations typically have long sales cycles and conservative adoption practices, demanding patience and persistence from technology providers. Regulatory requirements add another layer of complexity, with companies needing to navigate HIPAA compliance, FDA approvals, and evolving telehealth regulations. Brook’s success in securing significant funding suggests they’ve found effective strategies to address these hurdles, positioning themselves as a leader in what Grand View Research projects will be a $219 billion market by 2030, up from approximately $69 billion in 2024.
The impact of companies like Brook extends far beyond business metrics, touching the lives of individuals managing chronic conditions every day. For patients with congestive heart failure, diabetes, or hypertension, remote monitoring and support can mean fewer emergency room visits, reduced hospitalization risk, and greater independence. Healthcare providers benefit from more efficient use of clinical resources, continuous patient data rather than isolated office visits, and the ability to intervene earlier when problems arise. This transformation in care delivery is particularly meaningful as populations age and chronic disease prevalence increases globally. By combining human expertise with AI capabilities, Brook creates a more sustainable approach to chronic condition management that benefits patients, providers, and the healthcare system as a whole.
Looking ahead, Brook.ai’s latest funding round positions the company to further refine its technology and expand its market reach. As artificial intelligence continues to evolve, platforms like Brook’s will likely incorporate more sophisticated predictive analytics, personalized intervention strategies, and automated decision support tools. The company’s strong leadership team, with Nissim and Macgillivray’s proven track record in building and scaling technology businesses, provides a solid foundation for navigating future challenges. In a healthcare landscape increasingly focused on value-based care, prevention, and patient empowerment, Brook’s approach aligns perfectly with broader industry trends. Their continued growth will not only validate their business model but also contribute to reshaping how chronic conditions are managed in the 21st century – making quality healthcare more accessible, personalized, and effective for millions of patients managing long-term health conditions.
